There has been an ongoing public debate as to why many Canadians are not taking their medications as prescribed. Often, it is argued that non-adherence can be attributed to cost. The 10% figure that is frequently quoted publicly supporting this argument has become one of the main justifications for national pharmacare. A review of the literature reveals that much of the data around that question is outdated or uses limited survey questions.
Earlier this year, Innovative Medicines Canada and the Canadian Life and Health Insurance Association retained Nanos Research to conduct one of the largest national surveys of Canadians about their behaviours surrounding prescription medicine use.
Read the entire article HERE.